Fred Lublin
Acting Chairman · SIDNEY KIMMEL MEDICAL COLLEGE AT THOMAS JEFFERSON UNIVERSITY
Credentials: · · · ·
History
- 1972–1976
Neurology
Research
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria
Annals of Neurology · 2011 · 7,122 citations
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
Review · The Lancet Neurology · 2018 · 6,373 citations
Annals of Neurology · 2001 · 5,460 citations
41 papers
36 papers
28 papers
25 papers
- GC
22 papers
22 papers
19 papers
18 papers
Grants
- 2017–2024
MRI Predictors of Disease and Disability Progression in African Americans with Multiple Sclerosis
National Institute of Neurological Disorders and Stroke · R01
Contact PI · $2.5M · Icahn School of Medicine at Mount Sinai
- 2017–2023
Examining the Role of Brain Sodium Content in Multiplesclerosis Using MRI
National Institute of Neurological Disorders and Stroke · R01
Contact PI · $1.5M · Icahn School of Medicine at Mount Sinai
- 2003–2015
Extension of Combination Therapy for Multiple Sclerosis (eCombiRx)
National Institute of Neurological Disorders and Stroke · U01
Contact PI · $44.7M · Icahn School of Medicine at Mount Sinai
- 2001–2003
Combination Therapy in Multiple Sclerosis
National Institute of Neurological Disorders and Stroke · R21
Contact PI · $247.4K · Icahn School of Medicine at Mount Sinai
Clinical trials
- 2013–2018
Principal investigator · Unknown
Aaron Miller
- 2005–2013
Combination Therapy in Patients With Relapsing-Remitting Multiple Sclerosis (MS)CombiRx
Principal investigator · Completed · Phase 3
Fred Lublin
- 2003–2013
Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks
Principal investigator · Terminated · Phase 3
Fred Lublin
- 2002–2005
Immune Globulin Intravenous (IGIV) To Treat Relapsing, Remitting Multiple Sclerosis
Principal investigator · Completed · Phase 2
Grifols Therapeutics LLC